Concorde Asset Management, LLC Anixa Biosciences Inc Transaction History
Concorde Asset Management, LLC
- $183 Million
- Q1 2025
A detailed history of Concorde Asset Management, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Concorde Asset Management, LLC holds 13,969 shares of ANIX stock, worth $50,567. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,969
Previous 13,969
-0.0%
Holding current value
$50,567
Previous $34,000
14.71%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding ANIX
# of Institutions
71Shares Held
5.31MCall Options Held
14.1KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA1.39MShares$5.04 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC617KShares$2.23 Million0.28% of portfolio
-
D.A. Davidson & Co.614KShares$2.22 Million0.01% of portfolio
-
Ubs Group Ag505KShares$1.83 Million0.0% of portfolio
-
Mission Wealth Management, LP370KShares$1.34 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $111M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...